Journal of Virology, July 2001, p. 6321-6328, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6321-6328.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

HIV Drug Resistance Program1 and SAIC Frederick,2 National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, and Center for Advanced Biotechnology and Medicine and Rutgers University Chemistry Department, Piscataway, New Jersey 08854-56383
Received 5 January 2001/Accepted 12 April 2001
When human immunodeficiency virus type 1 (HIV-1) is selected for
resistance to 3TC, the methionine normally present at position 184 is
replaced by valine or isoleucine. Position 184 is the X of the
conserved YXDD motif; positions 185 and 186 form part of the triad of
aspartic acids at the polymerase active site. Structural and
biochemical analysis of 3TC-resistant HIV-1 reverse transcriptase (RT)
led to a model in which a
-branched amino acid at position 184 would
act as a steric gate. Normal deoxynucleoside triphosphates (dNTPs)
could still be incorporated; the oxathiolane ring of 3TCTP would clash
with the
branch of the amino acid at position 184. This model can
also explain 3TC resistance in feline immunodeficiency virus and human
hepatitis B virus. However, it has been reported (14) that
murine leukemia viruses (MLVs) with valine (the amino acid present in
the wild type), isoleucine, alanine, serine, or methionine at the X
position of the YXDD motif are all resistant to 3TC. We prepared
purified wild-type MLV RT and mutant MLV RTs with methionine,
isoleucine, and alanine at the X position. The behavior of these RTs
was compared to those of wild-type HIV-1 RT and of HIV-1 RT with
alanine at the X position. If alanine is present at the X position,
both MLV RT and HIV-1 RT are relatively resistant to 3TCTP in vitro.
However, the mutant enzymes were impaired relative to their wild-type
counterparts; there appears to be steric hindrance for both 3TCTP and
normal dNTPs.
Present address: E-Centive, Bethesda, MD 20817.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|